Table 1. Distribution of Various Clinical, Pathological, and Social Factors in the Cohort .
| Parameter | No. (%)a |
|---|---|
| Total No. | 400 |
| Age, median (IQR), y | 49 (41-56) |
| ≤60 | 336 (84.0) |
| >60 | 64 (16.0) |
| Sex | |
| Male | 334 (83.5) |
| Female | 66 (16.5) |
| Education | |
| <Secondary school | 150 (37.5) |
| >Secondary school | 250 (62.5) |
| Subsite | |
| Tongue | 175 (43.8) |
| Buccal mucosa, alveolus, or RMT | 212 (53.0) |
| Otherb | 13 (3.3) |
| Stage | |
| Early | 123 (30.8) |
| Advanced | 277 (69.3) |
| pT stage | |
| T1 | 74 (18.5) |
| T2 | 146 (36.5) |
| T3 | 65 (16.3) |
| T4a | 115 (28.7) |
| pN stage | |
| N0 | 232 (58.0) |
| N+ | 168 (42.0) |
| Adjuvant therapy | |
| Adjuvant RT | 205 (51.2) |
| Adjuvant CTRT | 143 (35.8) |
| Follow-up preference | |
| Every 3 mo | 276 (69.0) |
| Telephone questionnaire and every 6 mo | 124 (31.0) |
| Acceptability | |
| Yes | 385 (96.3) |
| No | 11 (2.8) |
| Maybe | 4 (1.0) |
| Financial implications of present visit | |
| Not at all | 9 (2.3) |
| Little bit | 96 (24.0) |
| Somewhat | 196 (49.0) |
| Very much | 99 (24.8) |
| Expenditure, median (IQR), ₹ | 5000 (2000-7000) |
| Duration of travel, median (IQR), h | 28.5 (20-36) |
Abbreviations: CTRT, chemoradiotherapy; IQR, interquartile range; pN, pathological nodal stage; pT, pathological tumor; RMT, retromolar trigone; RT, radiotherapy.
a
Values are expressed as No. (%) unless otherwise specified.
b
Other subsites consist of the floor of the mouth, lip, and palate.